🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Initial study in children with epilepsy to evaluate the pharmacokinetics, s...
Status
Completed
Location
108
Start Date
2011-07
Trial ID
NCT00422422
Treatments Being Tested
This study will estimate how fast two antiepileptic drugs (Levetiracetam an...
Status
Completed
Location
Ep0074 001
Start Date
2015-11
Trial ID
NCT02602860
Treatments Being Tested
The primary objective of this study is to compare the efficacy of Brivarace...
Status
Terminated
Location
3
Start Date
2014-03
Trial ID
NCT02088957
The purpose of the study is to evaluate the long-term safety and tolerabili...
Status
Recruiting
Location
Ep0156 259
Start Date
2021-03-11
Trial ID
NCT04715646
Treatments Being Tested
This study will evaluate the safety and tolerability of brivaracetam in ped...
Status
Completed
Location
N01266 243
Start Date
2011-08-01
Trial ID
NCT01364597
Treatments Being Tested
The purpose of the study is to investigate the long-term safety and tolerab...
Status
Active Not Recruiting
Location
Ep0224 50140
Start Date
2024-07-10
Trial ID
NCT06315322
Treatments Being Tested
The purpose of the study is to test the efficacy, safety and tolerability o...
Status
Completed
Location
N01269 115
Start Date
2021-07-29
Trial ID
NCT04666610
Treatments Being Tested
The purpose of the study is to evaluate the safety and tolerability of intr...
Status
Completed
Location
Ep0118 116
Start Date
2019-01-04
Trial ID
NCT03685630
Treatments Being Tested
The purpose of the study is to investigate the long-term safety, tolerabili...
Status
Completed
Location
Ep0132 115
Start Date
2022-03-30
Trial ID
NCT05109234
Treatments Being Tested
The goal of this clinical trial is to evaluate the bioequivalence of Brivar...
Status
Unknown
Location
Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School
Start Date
2024-10-21
Trial ID
NCT06762743